002742 冀衡醫藥
按盤價 
4.310 -0.390 (-8.298%)
4.310 -0.390 (-8.298%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -12.721 | 344.807 | 1,954.591 | -78.781 | -33.058 |
| 總資產報酬率 ROA (%) | -1.758 | -21.963 | -20.105 | -11.470 | -7.520 |
| 投入資產回報率 ROIC (%) | -2.459 | -54.933 | -59.413 | -25.239 | -13.856 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.100 | 15.680 | 18.253 | 19.047 | 15.271 |
| 營業利潤率 (%) | -6.643 | -45.653 | -47.481 | -13.612 | -9.806 |
| 息稅前利潤/營業總收入 (%) | -3.076 | -25.054 | -35.638 | -7.866 | -3.453 |
| 淨利潤/營業總收入 (%) | -8.609 | -50.985 | -54.340 | -20.161 | -14.039 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.498 | 72.205 | 41.993 | 27.328 | 52.572 |
| 價值變動淨收益/利潤總額(%) | 7.837 | -11.143 | -20.008 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 1.060 | 5.931 | 9.733 | 15.732 | 15.257 | 償債能力分析 |
| 流動比率 (X) | 1.307 | 1.226 | 0.411 | 0.541 | 0.603 |
| 速動比率 (X) | 0.727 | 0.734 | 0.329 | 0.459 | 0.511 |
| 資產負債率 (%) | 80.045 | 79.988 | 108.721 | 85.479 | 75.459 |
| 帶息債務/全部投入資本 (%) | 57.172 | 57.654 | 147.447 | 70.094 | 55.280 |
| 股東權益/帶息債務 (%) | 32.875 | 34.393 | -41.145 | 32.629 | 70.034 |
| 股東權益/負債合計 (%) | 16.908 | 17.605 | -14.424 | 10.516 | 26.313 |
| 利息保障倍數 (X) | -0.846 | -1.067 | -2.101 | -0.949 | -0.425 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 85.159 | 130.932 | 219.412 | 175.044 | 194.857 |
| 存貨周轉天數 (天) | 127.156 | 91.789 | 89.694 | 57.630 | 55.959 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
